NCT01919476

Brief Summary

Currently, about one third of all women entering pregnancy are obese. The prevalence of metabolic disorders during pregnancy has increased concurrently with the rise in maternal obesity. Although dietary interventions are used routinely to reduce metabolic disease in non-pregnant obese individuals, no specific dietary advice is provided to obese, pregnant women unless they develop gestational diabetes mellitus. In this study, the investigators will specifically assess the effect of replacing dairy fats with almonds in a breakfast meal on the postprandial metabolic response. This cross-over, randomized control trial will examine the postprandial metabolic response to 0 or 2 oz of almonds in standardized test meals in pregnant Hispanic women with prepregnancy BMI between 25 and 40. Hispanics are at higher risk for gestational diabetes and the metabolic syndrome. The investigators hypothesize that consuming almonds in place of dairy fat reduces the glycemic response and improves the postprandial lipid profile in these high-risk women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

July 31, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 9, 2013

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

November 24, 2020

Status Verified

November 1, 2020

Enrollment Period

4.5 years

First QC Date

July 31, 2013

Last Update Submit

November 20, 2020

Conditions

Keywords

PostprandialInsulin resistanceLipidsSatietyAlmonds

Outcome Measures

Primary Outcomes (1)

  • Change in markers for glucose intolerance.

    After consuming the breakfast meal markers for glucose intolerance will be measured at the time points listed

    0, .5, 1, 2, 3, 4, 5 hours following a meal

Secondary Outcomes (1)

  • Change in metabolic markers

    0, .5, 1, 2, 3, 4, 5 hours following a meal

Other Outcomes (1)

  • Change in satiety markers

    0, .5, 1, 2, 3, 4, 5 hours following a meal

Study Arms (2)

Control Meal: Bagel, cream cheese

ACTIVE COMPARATOR

Control meal consists of bagel with cream cheese and apple juice.

Other: BagelOther: Cream Cheese

Almond Meal: Bagel, almond butter

EXPERIMENTAL

Almond meal consists of bagel with almond butter and apple juice.

Other: BagelOther: Almond Butter

Interventions

BagelOTHER
Almond Meal: Bagel, almond butterControl Meal: Bagel, cream cheese
Control Meal: Bagel, cream cheese
Almond Meal: Bagel, almond butter

Eligibility Criteria

Age19 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant Hispanic women
  • Between 30 and 36 weeks gestation
  • Prepregnancy BMI between 25 and 40

You may not qualify if:

  • Diagnosis of gestational diabetes mellitus
  • Preexisting diabetes mellitus
  • Renal disease
  • Thyroid disease
  • Cardiovascular disease
  • History of drug abuse
  • Nut allergies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital Oakland Research Institute

Oakland, California, 94609, United States

Location

MeSH Terms

Conditions

Diabetes, GestationalInsulin Resistance

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperinsulinism

Study Officials

  • Janet C King, PhD

    Children's Hospital & Research Institute Oakland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2013

First Posted

August 9, 2013

Study Start

September 1, 2011

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

November 24, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations